Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 452, 176-180 (13 March 2008) | doi:10.1038/nature06722; Received 8 June 2007; Accepted 15 January 2008
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
- More Challenges
- Powered by:
nature jobs
Director of Bioinformatics
- University of the Witwatersrand, Johannesburg
- Johannesburg, South Africa
Post Doctoral
- University of Cambridge
- Cambridge, UK
A new class of anthelmintics effective against drug-resistant nematodes
Ronald Kaminsky1, Pierre Ducray2, Martin Jung1, Ralph Clover3, Lucien Rufener1,4, Jacques Bouvier1, Sandra Schorderet Weber1, Andre Wenger1, Susanne Wieland-Berghausen2, Thomas Goebel2, Noelle Gauvry2, François Pautrat2, Thomas Skripsky2, Olivier Froelich1, Clarisse Komoin-Oka5, Bethany Westlund3, Ann Sluder3 & Pascal Mäser4
- Novartis Centre de Recherche Santé Animale, CH-1566 St Aubin (FR), Switzerland
- Novartis Animal Health Inc., CH-4002 Basel, Switzerland
- Cambria Biosciences, Woburn, Massachusetts 01801, USA
- Institute of Cell Biology, University of Bern, CH-3012 Bern, Switzerland
- Laboratoire Central Vétérinaire de Bingerville, BP 206, Lanada, Côte d'Ivoire
Correspondence to: Ronald Kaminsky1 Correspondence and requests for materials should be addressed to R.K. (Email: ronald.kaminsky@novartis.com).
Abstract
Anthelmintic resistance in human and animal pathogenic helminths has been spreading in prevalence and severity to a point where multidrug resistance against the three major classes of anthelmintics—the benzimidazoles, imidazothiazoles and macrocyclic lactones—has become a global phenomenon in gastrointestinal nematodes of farm animals. Hence, there is an urgent need for an anthelmintic with a new mode of action. Here we report the discovery of the amino-acetonitrile derivatives (AADs) as a new chemical class of synthetic anthelmintics and describe the development of drug candidates that are efficacious against various species of livestock-pathogenic nematodes. These drug candidates seem to have a novel mode of action involving a unique, nematode-specific clade of acetylcholine receptor subunits. The AADs are well tolerated and of low toxicity to mammals, and overcome existing resistances to the currently available anthelmintics.
- Novartis Centre de Recherche Santé Animale, CH-1566 St Aubin (FR), Switzerland
- Novartis Animal Health Inc., CH-4002 Basel, Switzerland
- Cambria Biosciences, Woburn, Massachusetts 01801, USA
- Institute of Cell Biology, University of Bern, CH-3012 Bern, Switzerland
- Laboratoire Central Vétérinaire de Bingerville, BP 206, Lanada, Côte d'Ivoire
Correspondence to: Ronald Kaminsky1 Correspondence and requests for materials should be addressed to R.K. (Email: ronald.kaminsky@novartis.com).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Production of vaccines against gastrointestinal nematodes of livestockImmunology and Cell Biology Original Article
Thiabendazole: a Highly Effective Anthelmintic for SheepNature Letters to Editor (30 Sep 1961)
THE INDUCTION OF SELECTIVE IMMUNOLOGICAL UNRESPONSIVENESS IN CELLS OF BLOOD AND LYMPHOID TISSUE DURING PRIMARY INFECTION OF SHEEP WITH THE ABOMASAL NEMATODE, HAEMONCHUS CONTORTUSAustralian Journal of Experimental Biology and Medical Science Original Article
See all 21 matches for Research